Clinical Trial Update: Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates how VMX-C001 affects the anticoagulant effect of different forms of heparin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulation Disorders

Drugs mentioned

• Heparin (unfractionated heparin)
• VMX-C001 (VMX-C001)

Snippet

Sponsor: VarmX B.V. | Conditions: Coagulation Disorder | Phase 1 | Status: ACTIVE_NOT_RECRUITING